Le-Nguyen D - Search Results

1

Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins.

Lotersztajn S, Pavoine C, Brechler V, Roche B, Dufour M, Le-Nguyen D, Bataille D, Pecker F. Lotersztajn S, et al. J Biol Chem. 1990 Jun 15;265(17):9876-80. J Biol Chem. 1990. PMID: 2141022 Free article.

2

Role of G protein beta gamma subunits in the regulation of the plasma membrane Ca2+ pump.

Lotersztajn S, Pavoine C, Deterre P, Capeau J, Mallat A, LeNguyen D, Dufour M, Rouot B, Bataille D, Pecker F. Lotersztajn S, et al. J Biol Chem. 1992 Feb 5;267(4):2375-9. J Biol Chem. 1992. PMID: 1310315 Free article.

3

Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase.

Blache P, Kervran A, Dufour M, Martinez J, Le-Nguyen D, Lotersztajn S, Pavoine C, Pecker F, Bataille D. Blache P, et al. J Biol Chem. 1990 Dec 15;265(35):21514-9. J Biol Chem. 1990. PMID: 2147684 Free article.

4

Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon.

Blache P, Kervran A, Le-Nguyen D, Dufour M, Cohen-Solal A, Duckworth W, Bataille D. Blache P, et al. J Biol Chem. 1993 Oct 15;268(29):21748-53. J Biol Chem. 1993. PMID: 8408029 Free article.

5

Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon.

Pavoine C, Brechler V, Kervran A, Blache P, Le-Nguyen D, Laurent S, Bataille D, Pecker F. Pavoine C, et al. Am J Physiol. 1991 May;260(5 Pt 1):C993-9. doi: 10.1152/ajpcell.1991.260.5.C993. Am J Physiol. 1991. PMID: 1852111

6

[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane].

Blache P, Kervran A, Dufour M, Martinez J, Le-Nguyen D, Lotersztajn S, Pavoine C, Pecker F, Bataille D. Blache P, et al. C R Acad Sci III. 1989;308(17):467-72. C R Acad Sci III. 1989. PMID: 2499405 French.

7

Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway.

Dalle S, Smith P, Blache P, Le-Nguyen D, Le Brigand L, Bergeron F, Ashcroft FM, Bataille D. Dalle S, et al. J Biol Chem. 1999 Apr 16;274(16):10869-76. doi: 10.1074/jbc.274.16.10869. J Biol Chem. 1999. PMID: 10196164 Free article.

8

Miniglucagon: a local regulator of islet physiology.

Dalle S, Blache P, Le-Nguyen D, Le Brigand L, Bataille D. Dalle S, et al. Ann N Y Acad Sci. 1998 Dec 11;865:132-40. doi: 10.1111/j.1749-6632.1998.tb11171.x. Ann N Y Acad Sci. 1998. PMID: 9928005

9

Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.

Dalle S, Fontés G, Lajoix AD, LeBrigand L, Gross R, Ribes G, Dufour M, Barry L, LeNguyen D, Bataille D. Dalle S, et al. Diabetes. 2002 Feb;51(2):406-12. doi: 10.2337/diabetes.51.2.406. Diabetes. 2002. PMID: 11812748

10

Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B.

Fontés G, Lajoix AD, Bergeron F, Cadel S, Prat A, Foulon T, Gross R, Dalle S, Le-Nguyen D, Tribillac F, Bataille D. Fontés G, et al. Endocrinology. 2005 Feb;146(2):702-12. doi: 10.1210/en.2004-0853. Epub 2004 Nov 11. Endocrinology. 2005. PMID: 15539558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters